Results 11 to 20 of about 6,076 (222)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray [PDF]

World Allergy Organization Journal, 2008
Background Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction.
Leonard M. Fromer, Gabriel R. Ortiz, April M. Dowdee   +2 more
doaj   +2 more sources

Effects of nigella sativa oil on allergic rhinitis: an experimental animal study

Brazilian Journal of Otorhinolaryngology, 2022
Objectives: Nigella sativa oil is known antiallergic and immunomodulatory effects. We aimed to compare this oil with mometasone furoate, a topical steroid, on a rat model in the prevention of allergic rhinitis symptoms. Methods: A total of 28 two-to-four-
Recep Gul, Hasan Deniz Tansuker, Abdurrahman Bugra Cengiz, Melda Gul, Alper Tabaru, Funda Emre, Mehmet Faruk Oktay   +6 more
doaj   +1 more source

Role of Intranasal Topical Steroid in Pediatric Sleep Disordered Breathing and Influence of Allergy, Sinusitis, and Obesity on Treatment Outcome [PDF]

Clinical and Experimental Otorhinolaryngology, 2011
ObjectivesTo evaluate efficacy of short term intranasal corticosteroid (mometasone furoate) treatment in pediatric sleep-disordered breathing (SDB) patients.MethodsA prospective, observational study was done.
Yong Gi Jung, Hyo Yeol Kim, Jin-Young Min, Hun-Jong Dhong, Seung-Kyu Chung   +4 more
doaj   +1 more source

Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction

Life, 2022
Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 ...
Constantin A. Hintschich, Melanie Dietz, Antje Haehner, Thomas Hummel   +3 more
doaj   +1 more source

Comparison of Outcomes Between Mometasone Furoate Intranasal Spray and Oral Montelukast in Patients with Allergic Rhinitis

Journal of Nepal Health Research Council, 2020
Background: Allergic rhinitis is a common ailment with rising trend and worldwide prevalence of some 400 million. Methods: This prospective randomized crosssectional study was done at the Department of Otorhinolaryngology and Head and Neck Surgery ...
Sushma Bhattachan, Yogesh Neupane, Bibhu Pradhan, Naramaya Thapa   +3 more
doaj   +1 more source

Development of semisolid pharmaceutical forms with mometasone furoate

Acta Marisiensis - Seria Medica, 2023
This study aims to develop semisolid pharmaceutical forms for the topical administration of mometasone furoate.
Rédai Emőke Margit, Jakab Boglárka, Vlad Robert Alexandru, Antonoaea Paula, Todoran Nicoleta, Sipos Emese, Ciurba Adriana   +6 more
doaj   +1 more source

Validation of Mometasone furoate and CIP100 Residue Analysis Methods After Cleaning of Production Equipment in the “XYZ” Pharmaceutical Industry

Jurnal Kimia Sains dan Aplikasi, 2019
In this study, the HPLC and Total Organic Carbon (TOC) analysis methods have been developed and validated for the determination of the amount of Mometasone furoate and CIP100 residues on the surface of production equipment and to confirm the efficiency ...
Amaandika Galih Arintowibowo, Ririn Sumiyani, Kusuma Hendrajaya   +2 more
doaj   +1 more source

Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% [PDF]

, 2012
Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders.
Ayres JW, Borelli C, Brown PH, C. Schöllmann, C. Willers, Cornell RC, Dumas KJ, Faergemann J, H.C. Korting, Haigh JM, Hoffmann K, Hughes J, Katz HI, Kerscher MJ, Kirkland R, Koivukangas V, Korting HC, Korting HC, Korting HC, Korting HC, Kulhalli P, Medansky RS, Olsen EA, Poulsen J, Prakash A, Proksch E, Sequira J, Surber C, W. Wigger-Alberti, Wiedersberg S, Wilkinson SM   +30 more
core   +1 more source

SNG100, a novel topical treatment for moderate atopic dermatitis, in patients aged 6 years or older: A randomised, double‐blind, active‐controlled trial

Skin Health and Disease, 2023
Background Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. It is associated with significant itch and impaired quality of life. Systemic treatments are efficient but associated with side effects. Novel topical treatments with
Liat Samuelov, Avner Shemer, Shoshana Greenberger, Inbal Ziv, Doron Friedman, Oron Yacoby‐Zeevi, Roni Dodiuk‐Gad, Yuval Ramot, Sari Murad, Eli Sprecher   +9 more
doaj   +1 more source

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis [PDF]

, 2016
Background: Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis. These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and run down the throat and/or the nose, which, when unpleasant, can affect
Bremner, P, Dimitroff, A, Johnson, N, Luscombe, G, Prillaman, B, Rhee, C, Yanez, A   +6 more
core   +2 more sources